Silver Spike Investment Corp.

Good day and thank you for standing by. Welcome to the Silver Spike Investment Corp Fiscal Year End 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there'll be a question and answer session. To ask a question during the session, you will need to press star one and one on your telephone. You will then hear an automated message advising your hand is raised. To withdraw your question, please press star one one again. Please be advised that today's conference is being recorded. I would now like to hand the conference over to your first speaker today, Umesh Mahajan. Please go ahead, sir.

Thank you. Thank you, Sharon. Good morning. This is Umesh Mahajan, Chief Financial Officer of Silver Spike Investment Corp. With me here today is Corp Gordon, CEO of Silver Spike Investment Corp. Welcome to Silver Spike's earnings conference call and live webcast for the fiscal year end 2023. Silver Spike's financial results for the fiscal year ended December 31, 2023 were released yesterday and can be accessed from our website at ssic.silverspikecap.com. A replay of this call will also be available on our website later. Before we begin, I would like to remind everyone that certain statements that are not based on historical facts made during this call, including any statements related to financial guidance, may be deemed forward-looking statements under federal securities laws. because these forward-looking statements involve known and unknown risks and uncertainties that are important factors that could cause actual results to differ materially from those expressed or implied by these forward-looking statements. We encourage you to refer to our most recent SEC filings for information on some of these risk factors. Silver Spike assumes no obligation or responsibility to update any forward-looking statements. Please note that the information reported on this call speaks only as of today. March 28, 2024. Therefore, you're advised that time sensitive information may no longer be accurate at the time of any replay or transcript reading. With that said, good morning again and thank you all for joining today. We released our earnings yesterday and there's a management presentation deck attached to the 8K that was filed yesterday evening. Those who have joined us on this earnings webcast should also see a link to the slides We may refer to the slides by numbers for your reference as we walk through those pages. I'll cover the presentation slides to start and then turn it over to Scott Gordon for his thoughts and remarks. Turning to page three of our presentation, financial highlights for the quarter ended December 31st, 2023. The very first column shows the results for the quarter. Gross investment income of 3.6 million compared to 2.9 million in the previous quarter. Expenses of approximately 1.2 million, excluding expenses related to the loan portfolio acquisition, a transaction that we have previously announced but has not closed yet. Scott will discuss the transaction in more detail later in this presentation. We then have the loan portfolio acquisition expenses of 0.7 million, essentially legal expenses for the transaction incurred so far. We have net investment income of 1.7 million for the quarter. Again, this net investment income would have been higher if we exclude the impact of the loan portfolio acquisition expenses. Net investment income per share of 28 cents this quarter. Net assets of 85.6 million at the end of the period, down slightly from last quarter due to the payment of dividend. And our net asset value per share at December 31st is 13.77. There were no new investments this quarter. We'll discuss our origination efforts and our portfolio in more detail in subsequent slides. Also, our board declared a regular quarterly dividend of 25 cents per share. This dividend will be payable on March 28th today to shareholders on record as of March 20th. On page four, we show the financial highlights for the full year 2023. Please note that this was the first full year of operations for us. The comparison for the previous year is for nine months from April 1, 2022 till December 31st, 22. So for the fiscal year ended 2023, the first column, gross investment income of 11.9 million, total expenses of 5.3 million, which includes the 0.7 million expenses related to the loan portfolio acquisition, net investment income of 6.6 million. Again, this net investment income would have been higher if we exclude the impact of the loan portfolio acquisition expenses. Net investment income per share of $1.07. And we have paid a total dividend of $1.33 during the year ended 2023. We will not be covering the next few slides in the slide deck in detail as most of the investors are already familiar with our story. But turning to page 10, I would like to talk a little bit about the origination and the deal pipeline. Our deal pipeline remains very strong. In general, the last quarter of 23 was a slow period for loan transactions in the cannabis sector as a whole. To a large extent, there was an expectation among the cannabis operators that some progress on the rescheduling of cannabis is imminent. and that these borrowers should wait. At this point, many of those potential borrowers have figured it may be best to not necessarily wait for an update on the rescheduling front, and have begun to reengage with lenders like us. So we expect activity to pick up. In fact, the discussions have already picked up, and we have an active pipeline of over $420 million. We have used the slow period in the industry productively, by working on the loan portfolio acquisition transaction. So turning to page 12, we show our portfolio summary as of December 31. Companies A and B are Shrine and Pharmacan, which were investments we made last year in the summer. Company C is Curaleaf, 8% secured bonds that we had purchased at significant discount to the par value last year. Company D is one of our large positions in Verano. It's a first term loan transaction done in the last quarter of last year. And Company E represents Dreamfield Brands or Jeter. One of our portfolio companies, Marriamid, prepaid the loan along with a prepayment premium in the quarter ending December 31, 23. So overall, if you look at the top of the page, our total investment value is a little over $54 million. Average yield to maturity across all the loans is 18%. And a few additional points that we'd like to highlight about this portfolio and remind the investors to consider when they compare SSIC with other listed BDCs. First, all of our positions are first lien bonds or first lien loans or secure bonds. Second, none of our loans or bonds are in non-equal status. Third, all of, sorry, actually over 90% of our portfolio is in floating rate notes. And our gross portfolio yield of 18% compares quite favorably to the broader listed BDC universe. And we believe each of these portfolio companies is extremely well positioned in the industry for the longer term. With that, let me pass it on to Scott for his remarks.

Thank you, Umesh. Good morning, everybody. Just wanted to take a few moments to discuss the proposed loan portfolio acquisition. SSIC announced on February 20th of this year that it entered into a definitive agreement to purchase from Chicago Atlantic loan portfolio, portfolio of loans in exchange for newly issued shares of SSIC's common stock. This acquisition is expected to provide various benefits to SSIC and its stockholders, including increased scale and liquidity, enhanced portfolio diversification, improved access to debt and equity capital markets, and accretion to net investment income. Pro forma information following the closing of the loan portfolio acquisition, based on SSIC data as of December 31st, 2023, and the CALP loan portfolio data as of January 21st, January 1st, 2024, is the following. Pro forma net assets of approximately $213 million, including approximately $187 million of portfolio investments across 27 portfolio companies and approximately $25 million of cash. Approximately 19.1% pro forma combined gross weighted yield to maturity of the loan portfolio. SSIC's present officers will continue to be part of the SSIC management team following the loan portfolio acquisition. An anticipated closing is mid-2024, subject to satisfaction of customary closing conditions. In February, we also announced that our Board of Directors unanimously approved an expansion of our investment strategy to permit investments in companies outside of the cannabis and health and wellness sectors that otherwise meet our investment criteria. The investment strategy change is expected to become effective on or about April 22nd of this year. With that, I'll pass it back to Umesh.